![Enrique Castellón Leal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Enrique Castellón Leal
Directeur Général chez
Servizo Galego de Saúde CGA (Spain)
Profil
Enrique Castellón Leal is the founder of Cross Road Biotech Inversiones Biotecnologicas SGEIC SA, founded in 2001, holding the title of Founding Partner.
Mr. Castellón Leal was also the founder of Additum Blockchain SL, holding the title of Chief Executive Officer.
Current jobs include Chairman at Venter Pharma SL, Chairman at Health In Code SL, Chairman at Cross Road Biotech FCR, Director at One Way Liver SL, Director at Biocross SL, General Director at Servizo Galego de Saúde CGA (Spain), Director at Raman Health Technologies SL, Director at Advanced Cancer Prognostics Aie, Director at Atlas Molecular Pharma SL, and General Manager-Galician Health Service at Spain Ministry of Health, Social Services & Equality since 2010.
Former jobs include Chief Executive Officer at Genomadrid SL, Chief Executive Officer at Dendrico SL, Independent Director at Laboratorios Farmaceúticos Rovi SA from 2007 to 2019, Director at Traslational Cancer Drugs Pharma SL, Non-Executive Director at Metabolic Renal Disease SL, and Consultant-Health Policies at Inter-American Development Bank.
Education includes graduate degrees from Harvard University, Universidad Complutense de Madrid, and Universidad Autónoma de Madrid.
Postes actifs de Enrique Castellón Leal
| Sociétés | Poste | Début |
|---|---|---|
Cross Road Biotech Inversiones Biotecnologicas SGEIC SA
 Cross Road Biotech Inversiones Biotecnologicas SGEIC SA Investment ManagersFinance Cross Road Biotech Inversiones Biotecnologicas (CRB Inverbio) invests in companies located in Europe, mainly in Spain. The firm targets companies operating in the fields of healthcare, life sciences and biotechnology. It provides financing for early stage capital requirements with investment size ranging between EUR 2 million and EUR 4 million. It acquires both minority and majority interests. | Fondateur | 01/01/2011 |
Spain Ministry of Health, Social Services & Equality
 Spain Ministry of Health, Social Services & Equality General GovernmentGovernment Administers health & social welfare policies | Corporate Officer/Principal | 20/12/2010 |
Health In Code SL
 Health In Code SL Medical/Nursing ServicesHealth Services Operates as a medical laboratory and develops & manufactures disease diagnostic kits | Président | - |
Advanced Cancer Prognostics Aie | Directeur/Membre du Conseil | - |
One Way Liver SL
 One Way Liver SL Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of metabolomic profiling, analysis & diagnostic needs | Directeur/Membre du Conseil | - |
Biocross SL
 Biocross SL Medical SpecialtiesHealth Technology Designs and develops diagnostic products for neurodegenerative diseases | Directeur/Membre du Conseil | - |
Venter Pharma SL
 Venter Pharma SL Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Président | - |
Atlas Molecular Pharma SL
 Atlas Molecular Pharma SL Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of therapeutics for the treatment of patients suffering from rare diseases | Directeur/Membre du Conseil | - |
Servizo Galego de Saúde CGA (Spain) | Directeur Général | - |
| ░░░░░ ░░░░ ░░░░░░░ ░░░ | ░░░░░░░░░░ | - |
Anciens postes connus de Enrique Castellón Leal
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░ | - |
| ░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░ | - |
| ░░░░░░░░░░░░ ░░░░░░ ░░░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Enrique Castellón Leal
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
24
Relations au 1er degré
21
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 21 |
|---|---|
Inter-American Development Bank
 Inter-American Development Bank SupranationalGovernment Operates as a cooperative development bank | Government |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Laboratorios Farmaceúticos Rovi SA
 Laboratorios Farmaceúticos Rovi SA Pharmaceuticals: MajorHealth Technology Engages in the production and marketing of pharmaceutical products | Health Technology |
Universidad Complutense de Madrid
 Universidad Complutense de Madrid Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Venter Pharma SL
Venter Pharma SL Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Cross Road Biotech Inversiones Biotecnologicas SGEIC SA
Cross Road Biotech Inversiones Biotecnologicas SGEIC SA Investment ManagersFinance Cross Road Biotech Inversiones Biotecnologicas (CRB Inverbio) invests in companies located in Europe, mainly in Spain. The firm targets companies operating in the fields of healthcare, life sciences and biotechnology. It provides financing for early stage capital requirements with investment size ranging between EUR 2 million and EUR 4 million. It acquires both minority and majority interests. | Finance |
Universidad Autónoma de Madrid
 Universidad Autónoma de Madrid Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
One Way Liver SL
One Way Liver SL Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of metabolomic profiling, analysis & diagnostic needs | Commercial Services |
Genomadrid SL
 Genomadrid SL BiotechnologyHealth Technology Designs and develops diagnostic solutions for the detection of HIV | Health Technology |
Traslational Cancer Drugs Pharma SL
 Traslational Cancer Drugs Pharma SL BiotechnologyHealth Technology Discovers and develops therapeutic solutions for the treatment of cancer | Health Technology |
Biocross SL
Biocross SL Medical SpecialtiesHealth Technology Designs and develops diagnostic products for neurodegenerative diseases | Health Technology |
Dendrico SL
 Dendrico SL Miscellaneous Commercial ServicesCommercial Services Develops nanotechnology systems for diagnostics and therapeutics | Commercial Services |
Metabolic Renal Disease SL
 Metabolic Renal Disease SL Medical SpecialtiesHealth Technology Develops mass-spectrometry based tools for targeted metabolomics | Health Technology |
Servizo Galego de Saúde CGA (Spain) | |
Spain Ministry of Health, Social Services & Equality
Spain Ministry of Health, Social Services & Equality General GovernmentGovernment Administers health & social welfare policies | Government |
Health In Code SL
Health In Code SL Medical/Nursing ServicesHealth Services Operates as a medical laboratory and develops & manufactures disease diagnostic kits | Health Services |
Raman Health Technologies SL
 Raman Health Technologies SL BiotechnologyHealth Technology Researches and develops laser and spectroscopy-based diagnostic technology | Health Technology |
Advanced Cancer Prognostics Aie | |
Atlas Molecular Pharma SL
Atlas Molecular Pharma SL Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of therapeutics for the treatment of patients suffering from rare diseases | Commercial Services |
Cross Road Biotech FCR
 Cross Road Biotech FCR MiscellaneousMiscellaneous Operates as a non-classified establishment | Miscellaneous |
Additum Blockchain SL
 Additum Blockchain SL Packaged SoftwareTechnology Services Engages in develops blockchain and artificial intelligence technology to improve the patient health | Technology Services |
